15 النتائج
FIELD OF THE INVENTION
This invention relates to derivatives of pentose monosaccharides which exhibit anti-proliferative and anti-inflammatory activity as well as intermediate for the synthesis of these compounds. Compounds of the invention are useful for treating mammals with inflammatory and/or
I. FIELD OF THE INVENTION
The compounds of this invention are derivatives of simple monosaccharides which exhibit anti-proliferation and anti-inflammatory activity and are useful for treating mammals having inflammatory disorders and/or autoimmune disorders. This invention also encompasses
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom and a method for their preparation. These compounds exhibit
TECHNICAL FIELD
This invention relates to a novel preventive and curative agent for inflammatory bowel diseases. More particularly, this invention relates to a preventive and curative agent for inflammatory bowel diseases, using a water-soluble chromanol glucoside as an active ingredient.
BACKGROUND
Growth factors comprise a family of polypeptides with a manyfold of properties regulating for example cell proliferation and cell metabolism. As being multi-functional molecules, they may stimulate or inhibit cell proliferation as well as affect cell function depending on the type of the target
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to foreign patent application 1310/DEL/2006, filed May 30, 2006 in India.
FIELD OF THE INVENTION
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be
FIELD OF INVENTION
This invention generally relates to the derivatives of 5,6-dideoxy-.alpha.,D-5-epiglucofuranose, 5,6-dideoxy-.alpha.,D-5-epiallofuranose, 5,6-dideoxy-.alpha.,D-5-epimannofuranoside, 5-deoxy-.alpha.,D-lyxofuranoside, 5-deoxy-.alpha.,D-xylofuranose, 5-deoxy-.alpha.,D-ribofuranose,
FIELD OF THE INVENTION
This invention relates generally to compounds and processes for synthesizing derivatives of 2-3-O-isopropylidene-.alpha.-L-xylo-2-hexulofuranosonic acid. The compounds of this invention are useful, inter-alia, for the inhibition and prevention of cell adhesion and cell
FIELD OF THE INVENTION
This invention relates generally to compounds and processes for synthesizing derivatives of 2-3-O-isopropylidene-.alpha.-L-xylo-2-hexulofuranosonic acid. The compounds of this invention are useful, inter-alia, for the inhibition and prevention of cell adhesion and cell
FIELD OF THE INVENTION
This invention relates generally to compounds and processes for synthesizing derivatives of 2-3-O-isopropylidene-.alpha.-L-xylo-2-hexulofuranosonic acid. The compounds of this invention are useful, inter-alia, for the inhibition and prevention of cell adhesion and cell
FIELD OF THE INVENTION
This invention relates generally to compounds and processes for synthesizing derivatives of 2-3-O-isopropylidene-.alpha.-L-xylo-2-hexulofuranosonic acid. The compounds of this invention are useful, inter-alia, for the inhibition and prevention of cell adhesion and cell
FIELD OF THE INVENTION
This invention relates to sulfated oligosaccharides, their preparation and use as anti-angiogenic, anti-metastatic and/or anti-inflammatory agents.
BACKGROUND TO THE INVENTION
Heparan sulfates belong to the glycosaminoglycan family of polysaccharides. They are present in most
BACKGROUND
1. Field of the Invention
The present invention relates to 3,6-anhydro-L-galactose prepared through chemical and enzymatic methods and industrial use thereof using physiological efficacy.
2. Discussion of Related Art
Agar (or agarose) which is a main polysaccharide constituting a red alga
Growth factors comprise a family of polypeptides with a manyfold of properties regulating for example cell proliferation and cell metabolism. As being multi-functional molecules, they may stimulate or inhibit cell proliferation as well as affect cell function depending on the type of the target
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2009/005983, filed Oct. 16, 2009, which claims benefit of Korean Patent Application 10-2008-0102660, filed Oct. 20, 2008.
TECHNICAL FIELD
The